Literature DB >> 22542280

Coronary computed tomography angiography during arrhythmia: Radiation dose reduction with prospectively ECG-triggered axial and retrospectively ECG-gated helical 128-slice dual-source CT.

Ashley M Lee1, Leif-Christopher Engel, Baiju Shah, Gary Liew, Manavjot S Sidhu, Mannudeep Kalra, Suhny Abbara, Thomas J Brady, Udo Hoffmann, Brian B Ghoshhajra.   

Abstract

BACKGROUND: Arrhythmia during coronary computed tomography angiography (coronary CTA) acquisition increases the risk of nondiagnostic segments and high radiation exposure. An advanced arrhythmia rejection algorithm for prospectively electrocardiogram (ECG)-triggered axial scans using dual-source CT (DSCT) examinations has recently been reported.
OBJECTIVE: We compared image quality and effective dose at DSCT examinations using prospectively ECG-triggered axial scanning with advanced arrhythmia rejection software (PT-AAR) versus retrospectively ECG-gated helical scanning with tube-current modulation (RG-TCM) during arrhythmia.
METHODS: This was a retrospective case-control study of 90 patients (43 PT-AAR, 47 RG-TCM) with arrhythmia (defined as heart rate variability [HRV] > 10 beats/min during data acquisition) referred for physician-supervised coronary CTA between April 2010 and September 2011. A subset of 22 cases matched for body mass index, HR, HRV, and other scan parameters was identified. Subjective image quality (4-point scale) and effective dose (dose length product method) were compared.
RESULTS: PT-AAR was associated with lower effective dose than RG-TCM (4.1 vs 12.6 mSv entire cohort and 4.3 vs 9.1 mSv matched controls; both P < 0.01). Image quality scores were excellent in both groups (3.9 PT-AAR vs 3.6 RG-TCM) and nondiagnostic segment rates were low (0.1% vs 0.6%). Significantly higher image quality scores were found with PT-AAR in the entire cohort (P < 0.05), and in matched controls with high HRV > 28 beats/min (P < 0.05).
CONCLUSIONS: In patients with variable heart rates, prospectively ECG-triggered axial DSCT with arrhythmia rejection algorithm is feasible and can decrease radiation exposure by ∼50% versus retrospectively ECG-gated helical DSCT, with preserved image quality.
Copyright © 2012 Society of Cardiovascular Computed Tomography. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22542280     DOI: 10.1016/j.jcct.2012.04.003

Source DB:  PubMed          Journal:  J Cardiovasc Comput Tomogr        ISSN: 1876-861X


  15 in total

1.  Radiation dose reduction in pediatric cardiac computed tomography: experience from a tertiary medical center.

Authors:  Brian B Ghoshhajra; Ashley M Lee; Leif-Christopher Engel; Csilla Celeng; Mannudeep K Kalra; Thomas J Brady; Udo Hoffmann; Sjirk J Westra; Suhny Abbara
Journal:  Pediatr Cardiol       Date:  2013-07-20       Impact factor: 1.655

Review 2.  Important advances in technology and unique applications to cardiovascular computed tomography.

Authors:  Kongkiat Chaikriangkrai; Su Yeon Choi; Faisal Nabi; Su Min Chang
Journal:  Methodist Debakey Cardiovasc J       Date:  2014 Jul-Sep

3.  Assessment of Cardiac Lead Perforation: Comparison Among Chest Radiography, Transthoracic Echocardiography and Electrocardiography-gated Contrast-enhanced Cardiac CT.

Authors:  Xiang Zhang; Chushan Zheng; Peiwei Wang; Dongye Wang; Boshui Huang; Guozhao Li; Huijun Hu; Zehong Yang; Xiaohui Duan; Shaoxin Zheng; Pinming Liu; Jingfeng Wang; Jun Shen
Journal:  Eur Radiol       Date:  2018-07-17       Impact factor: 5.315

4.  Assessment of image quality and radiation dose of prospectively ECG-triggered adaptive dual-source coronary computed tomography angiography (cCTA) with arrhythmia rejection algorithm in systole versus diastole: a retrospective cohort study.

Authors:  Ashley M Lee; Jonathan Beaudoin; Leif-Christopher Engel; Manavjot S Sidhu; Suhny Abbara; Thomas J Brady; Udo Hoffmann; Brian B Ghoshhajra
Journal:  Int J Cardiovasc Imaging       Date:  2013-03-24       Impact factor: 2.357

5.  Coronary CT angiography in patients with atrial fibrillation: Standard-dose and low-dose imaging with a high-resolution whole-heart CT scanner.

Authors:  Anna Matveeva; Rainer R Schmitt; Karoline Edtinger; Matthias Wagner; Sebastian Kerber; Thomas Deneke; Michael Uder; Sebastian Barth
Journal:  Eur Radiol       Date:  2018-02-09       Impact factor: 5.315

Review 6.  Recent advances in cardiac computed tomography dose reduction strategies: a review of scientific evidence and technical developments.

Authors:  Sandeep S Hedgire; Vinit Baliyan; Brian B Ghoshhajra; Mannudeep K Kalra
Journal:  J Med Imaging (Bellingham)       Date:  2017-08-24

7.  Limits of the possible: diagnostic image quality in coronary angiography with third-generation dual-source CT.

Authors:  Marco M Ochs; Fabian Aus dem Siepen; Thomas Fritz; Florian Andre; Gitsios Gitsioudis; Grigorios Korosoglou; Sebastian Seitz; Yuriy Bogomazov; Christopher L Schlett; Roman Sokiranski; Andre Sommer; Friedemann Gückel; Matthias Brado; Hans-Ulrich Kauczor; Johannes Görich; Matthias G W Friedrich; Hugo A Katus; Sebastian J Buss
Journal:  Clin Res Cardiol       Date:  2017-02-06       Impact factor: 5.460

8.  State-of-the-Art Updates on Cardiac Computed Tomographic Angiography for Assessing Coronary Artery Disease.

Authors:  Joshua Schulman-Marcus; Ibrahim Danad; Quynh A Truong
Journal:  Curr Treat Options Cardiovasc Med       Date:  2015-08

9.  Defining the optimal systolic phase targets using absolute delay time for reconstructions in dual-source coronary CT angiography.

Authors:  Csilla Celeng; Harshna Vadvala; Stefan Puchner; Amit Pursnani; Umesh Sharma; Attila Kovacs; Pâl Maurovich-Horvat; Udo Hoffmann; Brian Ghoshhajra
Journal:  Int J Cardiovasc Imaging       Date:  2015-09-03       Impact factor: 2.357

10.  Prospectively ECG-triggered sequential dual-source coronary CT angiography in patients with atrial fibrillation: comparison with retrospectively ECG-gated helical CT.

Authors:  Lei Xu; Lin Yang; Zhaoqi Zhang; Yining Wang; Zhengyu Jin; Longjiang Zhang; Guangming Lu
Journal:  Eur Radiol       Date:  2013-05-04       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.